Type 1 diabetes is a disease that occurs when the immune system attacks and kills…
sciencecityOctober 3, 2019
A new monoclonal antibody has been shown to impede the fusion machinery henipaviruses use to…
sciencecityOctober 3, 2019
Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize…
sciencecityOctober 3, 2019
Genome editing means CRISPR to most people. Yet methods using zinc-finger nucleases, transcription activator-like effector…
sciencecityOctober 2, 2019
The National Institutes of Health has awarded $20 million to fund five additional hubs designed…
sciencecityOctober 2, 2019
OpenScope is now open for round two. The Allen Institute’s “shared observatory” for neuroscience has…
sciencecityOctober 2, 2019
NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the…
sciencecityOctober 1, 2019
They may not have made a dent against Alzheimer’s. But it turns out experimental drugs…
sciencecityOctober 1, 2019
Adaptive and Illumina to Make Immune Sequencing Kits for Labs, Streamlining the Detection of Disease
Adaptive Biotechnologies signed a deal with Illumina, the largest genetic sequencing firm in the U.S.,…
sciencecitySeptember 30, 2019
